CROI 2012: Michael Emerman


Michael Emerman, PhD, Fred Hutchinson Cancer Research Center, Seattle, WA.

Dr. Emerman presented at a CROI plenary, discussing why and how humans are susceptible to HIV, and therefore the genetic relationships to targets, and how to disrupt this process creating an antiviral effect. He also contributes his perspective on what he will take away from this year’s CROI.

No comments:

Post a Comment